Methotrexate vs Nivolumab
Methotrexate vs Nivolumab: Overview
This comparison examines the pharmacological differences between Methotrexate and Nivolumab.
Mechanism of Action
Methotrexate: Dihydrofolate reductase inhibitor.
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Pharmacokinetics
Half-life: Methotrexate β 3-10 hours; Nivolumab β 27 days.
Chemical Properties
Molecular Formula: Methotrexate β C20H22N8O5.
Molecular Weight: Methotrexate β 454.4400 g/mol.
Type: Methotrexate β Small molecule; Nivolumab β Antibody.